2RT
Nano-pulse laser therapy to slow the progression of AMD2RT® is a proprietary, minimally invasive nano-pulse ophthalmic laser therapy, which offers the potential to intervene earlier in the management of age-related macular degeneration (AMD) and thereby eliminate or delay the risk of vision-threatening complications associated with the disease.
Until now, there’s been little advance in treating AMD before it progresses to the vision-threatening complications associated with the late stage of the disease, referred to as Wet AMD. That’s why 2RT® represents such an important breakthrough.
A restorative treatment, 2RT® works stimulates rejuvenation of cells in the retina, initiating healing response that targets the underlying causes of AMD.
An extensive multi-centre clinical trial has shown that 2RT® achieves a four-fold reduction in the progression to late-stage AMD in 76% of selected intermediate AMD patients.
With 2RT®, ophthalmologists now have the potential to intervene sooner for the majority of intermediate AMD patients, before a significant threat to their vision occurs.
